FYU-981 + Febuxostat
Phase 3Completed 0 watching 0 views this week๐ Rising
76
Development Stage
โ
Pre-clinicalโ
Phase 1โ
Phase 24
Phase 35
ApprovedIndication / Disease
Hyperuricemia With or Without Gout
Conditions
Hyperuricemia With or Without Gout
Trial Timeline
Jan 9, 2018 โ Jul 5, 2018
NCT ID
NCT03372200About FYU-981 + Febuxostat
FYU-981 + Febuxostat is a phase 3 stage product being developed by Mochida Pharmaceutical for Hyperuricemia With or Without Gout. The current trial status is completed. This product is registered under clinical trial identifier NCT03372200. Target conditions include Hyperuricemia With or Without Gout.
Hype Score Breakdown
Clinical
27
Activity
18
Company
9
Novelty
9
Community
10
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT03372200 | Phase 3 | Completed |
Competing Products
20 competing products in Hyperuricemia With or Without Gout